Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chelsea Mayoh

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
Frontiers in Oncology|March 20, 2023
<i>In vivo</i> loss of tumorigenicity in a patient-derived orthotopic xenograft mouse model of ependymomaJacqueline P Whitehouse, Hilary Hii, Chelsea Mayoh, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 19, 2025
The Super Enhancer-Driven Long Noncoding RNA PRKCQ-AS1 Promotes Neuroblastoma Tumorigenesis by Interacting With MSI2 Protein and Is Targetable by Small Molecule CompoundsSujanna Mondal, Pei Y Liu, Janith Seneviratne, et al.
Leukemia|December 19, 2019
Effective targeting of NAMPT in patient-derived xenograft models of high-risk pediatric acute lymphoblastic leukemiaKlaartje Somers, Kathryn Evans, Leanna Cheung, et al.
Blood Cancer Journal|November 6, 2024
The third generation AKR1C3-activated prodrug, ACHM-025, eradicates disease in preclinical models of aggressive T-cell acute lymphoblastic leukemiaCara E Toscan, Hannah McCalmont, Amir Ashoorzadeh, et al.
Cancer Cytopathology|May 27, 2021
The important role of routine cytopathology in pediatric precision oncologyJinhan Xie, Amit Kumar, M Emmy M Dolman, et al.
Cell Reports|April 14, 2021
Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPGAnahid Ehteda, Sandy Simon, Laura Franshaw, et al.
NPJ Genomic Medicine|February 17, 2025
Returning raw genomic data to research participants in a pediatric cancer precision medicine trialKristine Barlow-Stewart, Eliza Courtney, Mark Cowley, et al.
NPJ Genomic Medicine|March 25, 2025
Author Correction: Returning raw genomic data to research participants in a pediatric cancer precision medicine trialKristine Barlow-Stewart, Eliza Courtney, Mark Cowley, et al.
Oncogene|March 4, 2021
A novel combination therapy targeting ubiquitin-specific protease 5 in MYCN-driven neuroblastomaBelamy B Cheung, Ane Kleynhans, Rituparna Mittra, et al.
Science Translational Medicine|January 14, 2026
Combined inhibition of FACT and BET disrupts transcription to suppress tumor growth in mouse models of diffuse midline gliomaHolly Holliday, Aaminah Khan, Anahid Ehteda, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
Frontiers in Oncology|March 20, 2023
<i>In vivo</i> loss of tumorigenicity in a patient-derived orthotopic xenograft mouse model of ependymomaJacqueline P Whitehouse, Hilary Hii, Chelsea Mayoh, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 19, 2025
The Super Enhancer-Driven Long Noncoding RNA PRKCQ-AS1 Promotes Neuroblastoma Tumorigenesis by Interacting With MSI2 Protein and Is Targetable by Small Molecule CompoundsSujanna Mondal, Pei Y Liu, Janith Seneviratne, et al.
Leukemia|December 19, 2019
Effective targeting of NAMPT in patient-derived xenograft models of high-risk pediatric acute lymphoblastic leukemiaKlaartje Somers, Kathryn Evans, Leanna Cheung, et al.
Blood Cancer Journal|November 6, 2024
The third generation AKR1C3-activated prodrug, ACHM-025, eradicates disease in preclinical models of aggressive T-cell acute lymphoblastic leukemiaCara E Toscan, Hannah McCalmont, Amir Ashoorzadeh, et al.
Cancer Cytopathology|May 27, 2021
The important role of routine cytopathology in pediatric precision oncologyJinhan Xie, Amit Kumar, M Emmy M Dolman, et al.
Cell Reports|April 14, 2021
Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPGAnahid Ehteda, Sandy Simon, Laura Franshaw, et al.
NPJ Genomic Medicine|February 17, 2025
Returning raw genomic data to research participants in a pediatric cancer precision medicine trialKristine Barlow-Stewart, Eliza Courtney, Mark Cowley, et al.
NPJ Genomic Medicine|March 25, 2025
Author Correction: Returning raw genomic data to research participants in a pediatric cancer precision medicine trialKristine Barlow-Stewart, Eliza Courtney, Mark Cowley, et al.
Oncogene|March 4, 2021
A novel combination therapy targeting ubiquitin-specific protease 5 in MYCN-driven neuroblastomaBelamy B Cheung, Ane Kleynhans, Rituparna Mittra, et al.
Science Translational Medicine|January 14, 2026
Combined inhibition of FACT and BET disrupts transcription to suppress tumor growth in mouse models of diffuse midline gliomaHolly Holliday, Aaminah Khan, Anahid Ehteda, et al.
Pageof 10